Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aptorum Group Ltd Cl A (APM)

Aptorum Group Ltd Cl A (APM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,916
  • Shares Outstanding, K 28,974
  • Annual Sales, $ 540 K
  • Annual Income, $ -18,690 K
  • 60-Month Beta -0.25
  • Price/Sales 66.07
  • Price/Cash Flow N/A
  • Price/Book 2.02
Trade APM with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.16 +131.03%
on 09/28/20
14.23 -81.17%
on 09/29/20
+0.56 (+26.42%)
since 08/28/20
3-Month
1.16 +131.03%
on 09/28/20
14.23 -81.17%
on 09/29/20
-1.11 (-29.29%)
since 06/30/20
52-Week
1.16 +131.03%
on 09/28/20
18.25 -85.32%
on 02/10/20
-13.83 (-83.77%)
since 09/30/19

Most Recent Stories

More News
Aptorum Group Announces Pricing of $9.0 Million Public Offering

Regulatory News:

APM : 2.68 (-43.70%)
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagnostics Technology To Track Pathogenic Genome

Regulatory News:

APM : 2.68 (-43.70%)
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach...

APM : 2.68 (-43.70%)
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation therapeutics targeting...

APM : 2.68 (-43.70%)
Aptorum Group Announces Video Update Discussing Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics...

APM : 2.68 (-43.70%)
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and oncology indications,...

APM : 2.68 (-43.70%)
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics...

APM : 2.68 (-43.70%)
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group" or the "Company"), a biopharmaceutical company focuses on the development of novel therapeutics to address global unmet medical...

APM : 2.68 (-43.70%)
LD Micro - 360 Companies Set to Present this Week

LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACRX : 1.4200 (-0.70%)
ACER : 2.88 (-7.99%)
ACU : 23.03 (+0.78%)
AT.VN : 1.610 (-0.62%)
AEY : 1.9200 (+1.59%)
ADIL : 2.23 (-26.40%)
ADTX : 1.9500 (+4.84%)
ADXS : 0.4100 (-2.61%)
AEHR : 1.3900 (-0.71%)
AIM : 2.15 (+1.42%)
AIRI : 1.2200 (-3.17%)
ALIM : 4.86 (-6.18%)
ALJJ : 0.7251 (+0.29%)
ALLT : 9.10 (-1.62%)
ARCT : 42.90 (+0.40%)
AREC : 1.5000 (-1.32%)
AMS : 1.8100 (-7.65%)
ANVS : 4.81 (+0.84%)
APEN : 1.6900 (+1.20%)
APM : 2.68 (-43.70%)
AQMS : 0.9110 (-1.47%)
AQB : 4.48 (-1.54%)
ARTL : 0.9926 (+11.53%)
ARHH : 0.8980 (+4.77%)
ATOM : 10.45 (-0.95%)
ATOS : 2.42 (-3.97%)
AUTO : 3.14 (-1.57%)
AYRO : 2.96 (-6.62%)
AZRX : 0.7110 (-1.77%)
BELFA : 11.71 (+4.30%)
BCDA : 2.27 (-2.16%)
BIOC : 4.41 (-2.65%)
BHTG : 1.4500 (+18.85%)
BIOL : 0.2751 (+0.77%)
BKEP : 1.5400 (-3.14%)
ATDS : 0.0091 (-3.19%)
ASUR : 7.55 (+0.80%)
BEER.VN : 0.055 (+10.00%)
ANY : 2.47 (-4.63%)
Aptorum Group Interview to Air on Bloomberg International on the RedChip Money Report

Regulatory News:

APM : 2.68 (-43.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aptorum Group Limited is a pharmaceutical company. It engaged in developing and commercializing therapeutic and diagnostic technologies to tackle unmet medical needs. The company's therapeutic and diagnostic project primarily includes neurology, infectious diseases, gastroenterology, oncology and other...

See More

Key Turning Points

2nd Resistance Point 3.45
1st Resistance Point 3.06
Last Price 2.68
1st Support Level 2.47
2nd Support Level 2.27

See More

52-Week High 18.25
Fibonacci 61.8% 11.72
Fibonacci 50% 9.70
Fibonacci 38.2% 7.69
Last Price 2.68
52-Week Low 1.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar